Antiangiogenic agents

Details for Australian Patent Application No. 2005222934 (hide)

Owner EntreMed, Inc.

Inventors Treston, Anthony; Lavallee, Theresa M.; Suwandi, Lita; Shah, Jamshed H.; Agoston, Gregory E.

Agent FB Rice

Pub. Number AU-B-2005222934

PCT Pub. Number WO2005/089256

Priority 60/562,793 16.04.04 US; 60/552,692 12.03.04 US

Filing date 11 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 17 June 2010

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 11/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/089256 Priority application(s): WO2005/089256

31 August 2006 Change of Name(s) of Applicant(s), Section 104

  EntreMed, Inc.; Agoston, Gregory; Shah, Jamshed The name of the applicant has been changed to EntreMed, Inc.

17 June 2010 Application Accepted

  Published as AU-B-2005222934

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222937-Method for treating aortic stenosis with non-antibacterial tetracycline formulations

2005222931-Methods and apparatus for integrated cell handling and measurements